Longitudinal study of medical downgrades in the Royal Air Force.


Journal

BMJ military health
ISSN: 2633-3775
Titre abrégé: BMJ Mil Health
Pays: England
ID NLM: 101761581

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 15 03 2021
revised: 28 04 2021
accepted: 29 04 2021
medline: 24 5 2023
pubmed: 27 5 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

As the focus of the Royal Air Force (RAF) shifts from sustained to contingency operations and the number of personnel is reduced, the burden of retained, medically downgraded personnel may affect operational readiness. The main aims were: to define the prevalence of morbidity leading to permanent medical downgrading; to determine at risk populations and identify areas for improvement. Database of personnel referred to the RAF Medical Board was analysed from January 2012 to October 2013 and January 2017 to December 2019. Patients were excluded if they did not require a formal medical board; incomplete and duplicate entries were also excluded. The primary reason for medical downgrade was categorised with an ICD-10 code. Further subanalysis compared musculoskeletal disease with age, individual trade groups and anatomic region. 2% of RAF service personnel were permanently downgraded annually. Musculoskeletal disease was the leading cause for permanent downgrade across both periods: 58% and 49%. Female personnel were at a greater risk of musculoskeletal downgrade compared with males. Spinal and knee pathology were the leading cause for downgrading among 'high risk' personnel. Personnel downgraded due to musculoskeletal pathology were often retained in a limited role with 10% and 5% retained as medically fully deployable. 14% and 12% of personnel downgraded due to musculoskeletal pathology were medically discharged. Musculoskeletal disease was the leading cause for permanent medical downgrades in the RAF. A greater proportion of downgraded personnel with musculoskeletal conditions were retained in service with medical limitations rather than medically discharged.

Identifiants

pubmed: 34035160
pii: bmjmilitary-2021-001839
doi: 10.1136/bmjmilitary-2021-001839
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-255

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Stefano Capella (S)

Trauma and Orthopaedics, Frimley Park Hospital, Frimley, UK s.capella@nhs.net.

E Demoulin (E)

Trauma and Orthopaedics, Harrogate and District NHS Foundation Trust, Harrogate, North Yorkshire, UK.

C Wilkinson (C)

Department of Occupational Medicine, RAF College Cranwell, Sleaford, Lincolnshire, UK.

P Hindle (P)

Trauma and Orthopaedic Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH